| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |